| DCPH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DCPH shares outstanding history going back to 9/28/2017:
Also see: DCPH Market Cap History DCPH YTD Return |
DCPH Shares Outstanding History — Deciphera Pharmaceuticals Share Count Over Time
As of 5/6/2024 Deciphera Pharmaceuticals has 86.48 million DCPH shares outstanding. Investors often track the DCPH shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DCPH share count trends over time, with 28 historical shares outstanding datapoints presented, dating back to 9/28/2017.
| DCPH Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DCPH Historical Shares Outstanding: +16.98% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DCPH Stock Price Chart |
| About Deciphera Pharmaceuticals Inc |
| Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. Using its proprietary switch-control kinase inhibitor platform and capabilities in kinase biology, Co. designs kinase inhibitors to target the switch pocket region of the kinase with the goal of developing medicines. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. Co. has developed a pipeline of drug candidates, including vimseltinib and DCC-3116. We show 28 historical shares outstanding datapoints in our coverage of DCPH's shares outstanding history. Understanding the changing numbers of DCPH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DCPH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DCPH by allowing them to research DCPH shares outstanding history as well as any other stock in our coverage universe. |
| DCPH Current Stock Quote |
Quotes delayed 20 minutes  Free DCPH Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DCPH Share Performance |
| Shares Outstanding Peers |
| Deciphera Pharmaceuticals (DCPH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DCTH Shares Outstanding History DEPO Shares Outstanding History DERM Shares Outstanding History DFFN Shares Outstanding History DFTX Shares Outstanding History DGX Shares Outstanding History DHR Shares Outstanding History DICE Shares Outstanding History DMK Shares Outstanding History DMPI Shares Outstanding History More Healthcare companies » |
DCPH Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
